Lv11
40 积分 2023-02-16 加入
Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity
8小时前
已完结
TCF3::BEND2 in paediatric supratentorial tumour with carcinoma‐like epithelial features classifying as MN1‐altered astroblastoma by DNA methylation profiling
14天前
已完结
Efficacy of EGFR tyrosine kinase inhibitors in patients with non–small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)
15天前
已完结
Long-term Survival Case of SCLC Transformation After Osimertinib Resistance in EGFR-mutant NSCLC: Benefits from Chemo-immunotherapy Combined with Anti-angiogenic Therapy Followed by Osimertinib Rechallenge
15天前
已完结
Tissue-specificity in cancer: The rule, not the exception
17天前
已完结
An Inflammatory Myofibroblastic Tumor With a Novel ALKV1180L Mutation Leading to Acquired Resistance to Tyrosine Kinase Inhibitors
17天前
已完结
Long-term Survival Case of SCLC Transformation After Osimertinib Resistance in EGFR-mutant NSCLC: Benefits from Chemo-immunotherapy Combined with Anti-angiogenic Therapy Followed by Osimertinib Rechallenge
30天前
已完结
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
30天前
已完结
ALK-EML4 fusion in small cell lung cancer: Clinical and molecular insights from a rare case
1个月前
已完结
Challenges and Opportunities of Emerging Mechanisms of Resistance to KRASG12C Inhibitors
1个月前
已完结
皖公网安备34019202002308
